Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy.

Journal of clinical laboratory analysis - 1 Jan 2001

Quiros-Roldan E, Signorini S, Castelli F, Torti C, Patroni A, Airoldi M, Carosi G

Abstract excerpt

The emergence of mutations encoding drug resistance is supposed to be a significant limitation to the clinical efficacy of inhibitor compounds directed against specific HIV-1 enzymatic targets. We have used a commercial test (Visible Genetics Inc., Paris, France) to study the prevalence of mutations occurred in HIV-1 protease and reverse transcriptase (RT) genes in 93 HIV-1 infected patients treated with at least...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to HIV Protease

Share to Mutation

Share to Reverse Transcriptase Inhibitors

Share to RNA-Directed DNA Polymerase

Source

Open in PubMed Open full text

Identifiers

PMID: 11170234
DOI: 10.1002/1098-2825(2001)15:1<43::aid-jcla9>3.0.co;2-i
PMCID: PMC6807694

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy.PMID 11170234Read ↗

Genotypic testing for human immunodeficiency virus type 1 drug resistance.Semantic proximity Read ↗

Navigating HIV-1 drug resistance: A comprehensive review of protease inhibitor efficacy and mutation dynamics.Semantic proximity Read ↗

Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece.Semantic proximity Read ↗

Determining and overcoming resistance to HIV protease inhibitors.Semantic proximity Read ↗

Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART.Semantic proximity Read ↗

Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors.Semantic proximity Read ↗

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.Semantic proximity Read ↗

Antiretroviral resistance mutations in human immunodeficiency virus type 1 infected patients enrolled in genotype testing at the Central Public Health Laboratory, São Paulo, Brazil: preliminary results.Semantic proximity Read ↗

Evaluation of the genotypic pattern of HIV-1 resistance in AIDS patients failing antiretroviral therapy.Semantic proximity Read ↗

Resistance of human immunodeficiency virus type 1 to reverse transcriptase and protease inhibitors: genotypic and phenotypic testing.Semantic proximity Read ↗

Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor.Semantic proximity Read ↗

Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.